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Objectives: Mood state heterogeneity in bipolar disorder leads to confusion in diagnosis and 
therapeutic strategies. Recently, the Systematic Treatment Enhancement Program for Bipolar 
Disorder (STEP-BD) showed that two-thirds of bipolar-depressed patients had concomitant 
manic symptoms, these characteristics being linked to a more severe form of bipolar disorder. 
Moreover, manic symptoms occurring during bipolar depression are associated with mood 
switches induced by antidepressant. It is thus important to best characterize mood episodes 
with mixed features in order to improve our understanding of the etiopathology and to choose 
the most appropriate treatment. As dimensional approach can better describe phenomena that 
are distributed continuously without clear boundaries, we used the MATHYS scale, 
constructed on a dimensional approach. The aim of the study is to determine whether two 
dimensions (activation/inhibition and emotional reactivity) improve assessment of bipolar 
states in which both manic and depressive symptoms are associated.  
Methods: We included 189 bipolar patients and 90 controls. Bipolar patients were 
distinguished between those with a major depressive episode without manic symptoms, a 
major depressive episode with manic symptoms, a mixed state and a manic state. The 
MATHYS scale provides a total score, quantifying an inhibition/activation process, and a 
score for emotional reactivity (intensity of emotions). Results: We demonstrated that there is 
a continuum ranging from inhibition to activation (respectively from major depressive 
episodes without manic symptoms to manic states), with a gradual increase in the severity of 
the activation. Regarding emotional reactivity, results are quiet different since only major 
depressive episodes without manic symptoms are characterized by emotional hypo-reactivity 
while major depressive episodes with manic symptoms, manic and mixed states exhibited 
emotional hyper-reactivity. Conclusions: The MATHYS scale, providing a score for 
inhibition/activation process and a score for emotional reactivity, is clearly useful to 
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distinguish bipolar depressive episodes without manic symptoms from those with manic 
symptoms. This last type of depression appears to belong to a broad spectrum of mixed state. 
To go further we need to explore if these two types of depression are underlined by different 
mechanisms and what is the most appropriate treatment for each of them.  
Key words: bipolar disorder, depressive state, mixed state, DSM-V, emotional reactivity, 
dimensional approach, MATHYS Scale.  
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Introduction 
Mood state heterogeneity in bipolar disorders has led to confusion in diagnosis and 
therapeutic strategies. Contrary to Kraepelin (1), who described six mixed states, DSM-IV (2) 
narrowly defines mixed episodes on the basis of full manic and full depressive syndromes 
being present at the same time, for at least one week, in only bipolar I patients. However, 
recent studies highlight the diversity of mood states in which both manic and depressive 
symptoms are associated. Koukopoulos was the first to draw attention to the need to recognize 
manic or hypomanic features that may arise in conjunction with bipolar depressive episodes 
(3). Benazzi (4) suggested defining “depressive mixed states” by the presence of three manic 
symptoms during bipolar II depressive episodes. Based on a broader ICD-10 (5) definition of 
a mixed episode, Suppes et al (6) described “mixed hypomania” for episodes simultaneously 
presenting hypomanic and depressive features. More recently, the Systematic Treatment 
Enhancement Program for Bipolar Disorder (STEP-BD) has shown that two-thirds of bipolar 
depressed patients had concomitant manic symptoms (7). In the STEP-BD study, patients 
with mixed features had more severe characteristics, such as illness onset at an early age, 
more bipolar I subtype, more rapid cycling in the past year, and a more frequent history of 
suicide attempts. Moreover, Frye et al. (8) showed that minimal manic symptoms at baseline 
coexisting with an otherwise full syndromal form of bipolar depression are associated with 
antidepressant treatment-emergent mania or hypomania. A better assessment of the 
differences between pure and mixed bipolar depression is of a great clinical significance, as it 
may offer potential indicators of short-term prognosis and may help in the prescription of 
psychotropic drugs.  
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On the other hand, Kraemer et al (9) have defined a dimensional approach, in which clinical 
presentations are classified based on quantitative attributes rather than the assignment to 
categories. It should work best if describing phenomena that are distributed continuously 
without clear boundaries. Thus, a dimensional approach appears to be appropriate for defining 
the spectrum of mixed episodes. To apply this concept to mixed states, we built and validated 
the MATHYS (Multidimensional Assessment of Thymic States) scale to define mood states 
as a function of a dimensional approach assessing symptoms on their quantitative aspects 
(acceleration/retardation; increase/decrease) (more details in the method section) (10). This 
scale provided a total score quantifying an overall level of inhibition/activation and a score of 
emotional reactivity (hypo versus hyper). We have previously shown that (11) emotional 
hyper reactivity (feeling emotions with a higher intensity than usual) characterizes mixed and 
manic states.  
We aimed 1) to determine whether only one scale (MATHYS) could be used to assess all 
bipolar mood episodes, and 2) to determine whether two dimensions (activation/inhibition; 
emotional reactivity) can help defining bipolar states in which both manic and depressive 
symptoms are associated.  
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Method 
Participants 
 Participants included control subjects and bipolar patients. Control subjects were 
recruited through advertisements in shopping areas and in sportive associations. Bipolar 
patients were in and outpatients recruited in a setting specialized in bipolar consultations or 
patients hospitalized in a department corresponding to a catchment area in Bordeaux (France). 
All patients had bipolar disorder, type I or II, and at the time of entry met the DSM-IV criteria 
for a full episode (depressed, manic or mixed). All subjects gave written informed consent, 
and the protocol was approved by the local ethics committee.   
Assessments 
All subjects (controls and bipolar patients) were assessed using the mood section of 
the French version of DIGS (Diagnostic Interview for Genetic studies), a structured interview 
providing DSM-IV diagnosis criteria (12). Severity of depressive and manic symptoms was 
further rated using the Montgomery-Asberg Depression Rating Scale (MADRS) (13) and the 
Bech and Rafaelsen Manic scale (MAS) (14).  
As there was no clinical tool to assess bipolar mood states dimensionally, we 
developed and validated a dimensional self-rated scale: MATHYS (Multidimensional 
Assessment of Thymic States). This scale was built a priori, with five quantitative 
dimensions, which vary from inhibition to activation. The goal was to generate a total score 
indicative of the overall level of inhibition/activation. Thus, classic dimensions, such as 
cognition, motivation, psychomotor agitation or retardation and sensory perception, were 
assessed quantitatively (i.e., racing thoughts or subjectively feeling that their thoughts occur 
slower, physical agitation or retardation, and increase or decrease in sense perception) 
(Example: My brain never stops/ My brain seems to be functioning in slow motion). We 
applied a similar concept to evaluate emotion, focusing only on the quantitative aspect (ie, 
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whether the patient felt emotion with normal intensity, greater intensity, or less intensity) 
(Example: My emotions are very intense/ My emotions are attenuated) 
The concept behind this scale involved exploring all bipolar mood states on a continuum 
using a score for inhibition/activation and exploring emotional reactivity rather than tonality 
of affect (euphoria/sadness). Manic and mixed states were better characterized by emotional 
hyper-reactivity, suggesting that all patients felt emotions with an unusual intensity, 
irrespective of the emotion (sadness, irritability, euphoria, and anxiety) (11). The scale is 
composed of a visual analog scale comprising 20 items related to how the individual feels 
during the previous week. Statistical analyses demonstrated a good validity for this scale, and 
a good internal consistency (Cronbach’s alpha coefficient = 0.95). The MATHYS scale is 
moderately correlated of both the MADRS scale (depressive score; r = -0.45) and the MAS 
scale (manic score; r = 0.56). 
This scale gives a total score assessing the activation/inhibition level and a score for 
emotional reactivity (hyper/hyporeactivity) (the English version of the scale can be found by 
following this link: [http://www.biomedcentral.com/content/supplementary/1471-244X-8-82-
S1.doc] (10).  
 
Statistical analyses 
Groups (bipolar mood episodes and control) were compared based on MATHYS, MADRS 
and MAS scales. Statistical methods consisted of Chi-square tests for comparisons of 
categorical variables (sex) and analysis of variance (ANOVA) for continuous variables: 
[MATHYS (total score and score of emotional reactivity), age, MADRS, MAS]. The score for 
emotional reactivity was obtained by adding items 3, 7, 10 and 18 (define by a principal 
component analysis, Henry et al., 2008). Post-hoc analysis using Tukey's procedure was used 
to calculate mean differences and to determine which means were significantly different from 
 8 
one another. Finally, we analyzed whether there was a trend in the mean differences between 
bipolar mood episodes. Testing was 2-sided, with a significance level of 5%. Two-sided p 
values of 0.05 were considered statistically significant. We used SAS software (version 9.1; 
SAS Institute) for the analysis.  
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Results 
 
Characteristics of the groups 
The total sample of 279 subjects (189 bipolar patients and 90 controls) was composed of 92 
(33%) men and 187 (67%) women, with a mean age at interview of 39.3 (±13.1) [14-72] 
years. There is no difference between control subjects and bipolar patients for age and gender. 
A total of 54.9% of patients (n=96) met the criteria for bipolar type I disorder. Among bipolar 
patients and according to DSM-IV criteria, 51 patients (27 %) had a major depressive episode 
without manic symptoms, 21 (11.1%) had mixed episodes, and 54 (28.6%) had hypomanic or 
manic episodes. As defined by STEP-BD (Golberg et al., 2009), 63 (33.3%) patients 
presented a major depressive episode associated with manic symptoms, but these patients did 
not fulfil the DSM-IV criteria for a mixed episode.   
As expected, all groups had different MADRS scores (F=152.4; ddl=4; p<0.0001). The 
highest score was observed for patients in a major depressive episode without manic 
symptoms and manic patients exhibited the lowest score. All groups had also different scores 
on the manic scale (MAS) (F=142.9; ddl=4; p<0.0001). The highest score was found in the 
manic group 17.6 (±6.8) while the group with a major depressive episode exhibited 1.3 (±2.1) 
and patients with a major depressive episode associated with manic symptoms had a mean 
score at 7.6 (±4.3).  
Dimensional characterization  
The total scores within all groups, based on the MATHYS scale for assessing 
inhibition/activation, were different (F=95.8; ddl=4; p<0.0001). The total score increased 
progressively from major depressive episode without manic symptoms to manic states 
(ranging from 58.6±27 for major depressive episode to 142.4±27.9 for manic states) (Table 1 
and figure1).  
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Post-hoc analysis showed that the total score based on the MATHYS scale was different 
between the two subtypes of depression. Patients, with a major depressive episode without 
manic symptoms, exhibited lower scores than those with a major depressive episode with 
manic symptoms. By contrast, scores for major depressive episode with manic symptoms 
were not different for those from mixed states.  
The score assessing emotional reactivity was statistically different if the whole sample was 
considered (F=64.9; ddl=4; p<0.0001)(table 1 and figure 2). Post-hoc analysis showed that 
there were no difference among the scores for major depressive episode with manic 
symptoms, mixed states and manic states. By contrast, major depressive episodes without 
manic symptoms exhibited the lowest score among all groups. Relative to controls, and 
representative of normal emotional reactivity, depressed patients without manic symptoms 
had emotional hyporeactivity, whereas those with major depressive episode with manic 
symptoms exhibited emotional hyperreactivity.  
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Discussion 
 
Our results showed that the different bipolar mood states can be assessed using only one-
dimensional MATHYS scale which classifies the mood episodes using a continuum ranging 
from inhibition to activation. Major depressive episodes without manic symptoms displayed 
lower scores, underlying overall inhibition. As expected, the manic group had a higher 
activation score. Major depressive states associated with manic symptoms had scores that 
were similar to those of mixed states, as defined by DSM-IV (2).  
Emotional reactivity clearly helped to distinguish major depressive episodes without manic 
symptoms from those with manic symptoms. The first group was characterized by emotional 
hypo-reactivity, defined by a lower score than the mean value of the control group. By 
contrast, depressive episodes with manic symptoms exhibited emotional hyper-reactivity, 
such as mixed and manic states. Emotional reactivity is therefore a relevant dimension for 
differentiating between the two types of depression.  
Current classifications partly neglect emotional reactivity. Anhedonia, the inability to feel 
pleasure, is a characteristic of melancholia in the DSM-IV (2). However, in its most complete 
form, emotional hyporeactivity can also affect negative stimulation, resulting in an inability 
for the subject to react to any stimulation. By contrast, emotional reactivity is mentioned in 
DSM-IV as a feature of atypical depression, but only in response to pleasant stimulation. One 
must consider that high emotional reactivity should also be factored into negative situations, 
leading to excessive or inappropriate irritability, anger, sadness or despair. Thus, emotional 
hyperreactivity can have different tonalities of affect: euphoria in manic episodes, high 
lability in mixed states and more negative affects during agitated depression.   
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Our findings confirmed those reported by the STEP-BD and other studies, in that there is a 
need to better characterize bipolar depressive states with and without manic symptoms (7,8, 3, 
4). A dimensional approach provides more information on the phenotype of the two types of 
depression. One was characterized by overall inhibition linked to a decrease in cognitive 
function, psychomotor retardation, a decrease in sense perception and emotional hypo-
reactivity. The other type of depression was obviously similar to a mixed episode, as defined 
by the DSM-IV (2), but did not fulfil the criteria. New classifications must take into account 
these dimensional aspects. Psychomotor agitation or retardation is one out of nine items in the 
DSM-IV criteria that point to a major depressive episode. Unfortunately, these two opposite 
states belong to the same item. The same is true for the loss or gain of weight and for 
insomnia versus hypersomnia. However, opposite features are not governed by the same 
mechanisms. New classifications have to take into account this aspect to avoid to include in a 
same category, states underlined by different mechanisms that can distort research results.  
Using current classification or classical scales, the broad spectrum of mixed states was 
defined by counting the number of symptoms belonging to manic and to depressive episodes 
or in characterizing episodes using both a depressive and a manic scale. This led to some 
confusion over a clear definition. Using a single, valid clinical tool that assessed levels of 
inhibition/activation and emotional reactivity was clearly useful in defining this spectrum of 
states.  
Distinguishing the various sub-forms of depression is highly important in clinical practice.  
Choosing the most appropriate treatment for each form of depression is not easy and recent 
guidelines regarding the treatment of bipolar depression are not very helpful. Actually, they 
recommend on the same line all kinds of treatment including mood stabilizers, atypical 
antipsychotics and antidepressant (15, 16).  The choice of whether to use an antidepressant or 
an atypical antipsychotic in bipolar depression would be facilitated by distinguishing 
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inhibited/emotional hypo reactive depression from activated/emotional hyper reactive 
depression.   
This study is the first one using a new dimensional scale that compares all bipolar mood states 
as a function of a level of activation/inhibition and emotional reactivity. To go further we 
need to perform a follow up in order to assess if recurrences of mood states and more 
particularly depressive episodes exhibit the same characteristics in a same patient. Moreover, 
further studies are needed to find biomarkers that characterize each group.  
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